Literature DB >> 27035427

miR‑19a‑3p targets PMEPA1 and induces prostate cancer cell proliferation, migration and invasion.

Sujuan Feng1, Xuhui Zhu1, Bohan Fan1, Dawei Xie1, Tao Li1, Xiaodong Zhang1.   

Abstract

Prostate cancer (PCa) is one of the most common malignant tumors in men. Studies have observed that microRNA (miR)‑19a‑3p expression levels are downregulated in several types of cancer, and yet the biological function and its underlying mechanisms in the pathogenesis of PCa remain unclear. In the current study, the expression pattern of miR‑19a‑3p in PCa tissues and cell lines was detected by reverse transcription‑quantitative polymerase chain reaction. The proliferative, migratory and invasive capacity of PCa cells were determined using EdU and Transwell assays following transfection with miR‑19a‑3p mimics. Additionally, the current study investigated the biological impact and regulation of prostate transmembrane protein androgen induced 1 (PMEPA1) in PCa cells by transfection with PMEPA1 small interfering (si)RNA. It was observed that miR‑19a‑3p was upregulated in PCa tissue samples and cell lines in vitro. Functional analysis also confirmed that miR‑19a‑3p overexpression promoted the proliferation, migration and invasion of PCa cells. Furthermore, PMEPA1 was identified as a direct target of miR‑19a‑3p, and siRNA knockdown of PMEPA1 resulted in increased proliferation, migration and invasion of PCa cells, which partially accounts for the effect of miR‑19a‑3p in tumor metastasis. In conclusion, the findings of the present study suggest that the upregulation of miR‑19a‑3p expression levels contributes to tumor progression and that one of its underlying mechanisms involves inhibition of PMEPA1 expression.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27035427     DOI: 10.3892/mmr.2016.5033

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   2.952


  7 in total

1.  CSDE1 attenuates microRNA-mediated silencing of PMEPA1 in melanoma.

Authors:  Pavan Kumar Kakumani; Tanit Guitart; Francois Houle; Louis-Mathieu Harvey; Benjamin Goyer; Lucie Germain; Fátima Gebauer; Martin J Simard
Journal:  Oncogene       Date:  2021-04-08       Impact factor: 9.867

2.  Genome-wide DNA methylation sequencing reveals miR-663a is a novel epimutation candidate in CIMP-high endometrial cancer.

Authors:  Megumi Yanokura; Kouji Banno; Masataka Adachi; Daisuke Aoki; Kuniya Abe
Journal:  Int J Oncol       Date:  2017-04-19       Impact factor: 5.650

3.  Peptide T7-modified polypeptide with disulfide bonds for targeted delivery of plasmid DNA for gene therapy of prostate cancer.

Authors:  Yue Lu; Wenjun Jiang; Xin Wu; Saixu Huang; Zhiyong Huang; Yamin Shi; Qi Dai; Jianming Chen; Fuzheng Ren; Shen Gao
Journal:  Int J Nanomedicine       Date:  2018-10-30

4.  Study on the cellular internalization mechanisms and in vivo anti-bone metastasis prostate cancer efficiency of the peptide T7-modified polypeptide nanoparticles.

Authors:  Yongwei Gu; Xinmei Chen; Haiyan Zhang; Heyi Wang; Hang Chen; Sifan Huang; Youfa Xu; Yuansheng Zhang; Xin Wu; Jianming Chen
Journal:  Drug Deliv       Date:  2020-12       Impact factor: 6.419

5.  Analysis of PMEPA1 Isoforms (a and b) as Selective Inhibitors of Androgen and TGF-β Signaling Reveals Distinct Biological and Prognostic Features in Prostate Cancer.

Authors:  Shashwat Sharad; Zsófia M Sztupinszki; Yongmei Chen; Claire Kuo; Lakshmi Ravindranath; Zoltan Szallasi; Gyorgy Petrovics; Taduru L Sreenath; Albert Dobi; Inger L Rosner; Alagarsamy Srinivasan; Shiv Srivastava; Jennifer Cullen; Hua Li
Journal:  Cancers (Basel)       Date:  2019-12-12       Impact factor: 6.639

6.  Diagnostic and Prognostic Value of MicroRNAs in Metastasis and Recurrence of Head and Neck Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis.

Authors:  Ke Qiu; Yao Song; Yufang Rao; Qiurui Liu; Danni Cheng; Wendu Pang; Jianjun Ren; Yu Zhao
Journal:  Front Oncol       Date:  2021-09-27       Impact factor: 6.244

Review 7.  Regulation of Neuroendocrine-like Differentiation in Prostate Cancer by Non-Coding RNAs.

Authors:  Eva Slabáková; Zuzana Kahounová; Jiřina Procházková; Karel Souček
Journal:  Noncoding RNA       Date:  2021-12-02
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.